Back to results
US 12,582,640 B2Granted
Treatment of lower respiratory tract infection with tradipitant
AssigneeVanda Pharmaceuticals Inc.
InventorsMihael H. Polymeropoulos, Christos Polymeropoulos, Vasilios Polymeropoulos, Changfu Xiao
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method of treatment of a lower respiratory tract infection caused by, e.g., coronavirus disease (COVID-19), influenza, or other virus, comprising treatment with the NK-1 receptor antagonist, tradipitant.
Claims20
A method of treatment of a patient diagnosed with a lower respiratory tract infection, the method comprising:
- administering to the patient tradipitant at a dose effective to treat the lower respiratory tract infection or at least one symptom thereof.
Dependencies are inferred from the claim text.